ARFLEYDA Trademark

Trademark Overview


On Friday, January 28, 2022, a trademark application was filed for ARFLEYDA with the United States Patent and Trademark Office. The USPTO has given the ARFLEYDA trademark a serial number of 79337591. The federal status of this trademark filing is REGISTERED as of Tuesday, October 3, 2023. This trademark is owned by R-PHARM INTERNATIONAL, LLC. The ARFLEYDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of familial Mediterranean fever; Pharmaceutical preparations for the treatment of adult-onset Still's disease; Pharmaceutical preparations for the treatment of idiopathic recurrent pericarditis; Pharmaceutical preparations for the treatment of recurrent pericarditis; Pharmaceutical preparations for secondary prevention of major adverse cardiovascular events after ST-elevation myocardial infarction; Pharmaceutical preparations for the treatment of chronic heart failure; Pharmaceutical preparations for the treatment of macrophage activation syndrome; Pharmaceutical preparations for the treatment of systemic juvenile idiopathic arthritis; Pharmaceutical preparations for the treatment of cryopyrin-associated periodic syndromes; Pharmaceutical preparations for the treatment of tumor necrosis factor receptor associated periodic syndrome; Pharmaceutical preparations for the treatment of Schnitzler syndrome; Pharmaceutical preparations for the trea...
arfleyda

General Information


Serial Number79337591
Word MarkARFLEYDA
Filing DateFriday, January 28, 2022
Status700 - REGISTERED
Status DateTuesday, October 3, 2023
Registration Number7178346
Registration DateTuesday, October 3, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of familial Mediterranean fever; Pharmaceutical preparations for the treatment of adult-onset Still's disease; Pharmaceutical preparations for the treatment of idiopathic recurrent pericarditis; Pharmaceutical preparations for the treatment of recurrent pericarditis; Pharmaceutical preparations for secondary prevention of major adverse cardiovascular events after ST-elevation myocardial infarction; Pharmaceutical preparations for the treatment of chronic heart failure; Pharmaceutical preparations for the treatment of macrophage activation syndrome; Pharmaceutical preparations for the treatment of systemic juvenile idiopathic arthritis; Pharmaceutical preparations for the treatment of cryopyrin-associated periodic syndromes; Pharmaceutical preparations for the treatment of tumor necrosis factor receptor associated periodic syndrome; Pharmaceutical preparations for the treatment of Schnitzler syndrome; Pharmaceutical preparations for the treatment of acute gout attacks

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameR-PHARM INTERNATIONAL, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressRU

Party NameR-PHARM INTERNATIONAL, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRU

Party NameR-PHARM INTERNATIONAL, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRU

Trademark Events


Event DateEvent Description
Tuesday, January 30, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, January 5, 2024FINAL DISPOSITION NOTICE SENT TO IB
Friday, January 5, 2024FINAL DISPOSITION PROCESSED
Wednesday, January 3, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 3, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, October 3, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 3, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, September 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, June 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 14, 2023REFUSAL PROCESSED BY IB
Tuesday, January 24, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, January 24, 2023REFUSAL PROCESSED BY MPU
Saturday, November 19, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, November 18, 2022NON-FINAL ACTION WRITTEN
Wednesday, November 9, 2022ASSIGNED TO EXAMINER
Tuesday, April 12, 2022APPLICATION FILING RECEIPT MAILED
Friday, April 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 7, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB